External News
- Survivornet
‘Game-Changing’ Drug Enhertu Now Approved for Certain Types of Lung Cancer — What Does This Mean for Patients?
- MedPage Today
ASCO 2032: What Will Be the Big Story in Lung Cancer?
- Medpage Today
Top Takeaways in Lung Cancer From ASCO 2022
- Medpage Today
Neoadjuvant Chemo Plus Immunotherapy in Resectable NSCLC
- MSN.com
Lung Cancer Patients Who Took Experimental Drugs Combo Lived Longer
- OncologyTube
Video: Dr. Roy S. Herbst on the Phase II S1800A Trial
- eCancer
Video: Ramucirumab plus pembrolizumab Improves OS in Advanced NSCLC
- Medical Dialogues
New Drug Combination Improves Survival for Some with Lung Cancer
Dr. Roy S. Herbst honored at Friends of Cancer Research 25th Anniversary Dinner
Yale Cancer Center and Smilow Cancer Hospital physicians recognized as Connecticut Magazine 'Best Doctors'